Literature DB >> 21810062

Oral formulation strategies to improve solubility of poorly water-soluble drugs.

Abhishek Singh1, Zelalem Ayenew Worku, Guy Van den Mooter.   

Abstract

INTRODUCTION: In the past two decades, there has been a spiraling increase in the complexity and specificity of drug-receptor targets. It is possible to design drugs for these diverse targets with advances in combinatorial chemistry and high throughput screening. Unfortunately, but not entirely unexpectedly, these advances have been accompanied by an increase in the structural complexity and a decrease in the solubility of the active pharmaceutical ingredient. Therefore, the importance of formulation strategies to improve the solubility of poorly water-soluble drugs is inevitable, thus making it crucial to understand and explore the recent trends. AREAS COVERED: Drug delivery systems (DDS), such as solid dispersions, soluble complexes, self-emulsifying drug delivery systems (SEDDS), nanocrystals and mesoporous inorganic carriers, are discussed briefly in this review, along with examples of marketed products. This article provides the reader with a concise overview of currently relevant formulation strategies and proposes anticipated future trends. EXPERT OPINION: Today, the pharmaceutical industry has at its disposal a series of reliable and scalable formulation strategies for poorly soluble drugs. However, due to a lack of understanding of the basic physical chemistry behind these strategies, formulation development is still driven by trial and error.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21810062     DOI: 10.1517/17425247.2011.606808

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  24 in total

1.  A new twist in the old story-can compression induce mixing of phase separated solid dispersions? A case study of spray-dried miconazole-PVP VA64 solid dispersions.

Authors:  Abhishek Singh; Jan Van Humbeeck; Guy Van den Mooter
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

2.  The influence of drug solubility and sampling frequency on metformin and glibenclamide release from double-layered particles: experimental analysis and mathematical modelling.

Authors:  T Shams; F Brako; S Huo; A H Harker; U Edirisinghe; M Edirisinghe
Journal:  J R Soc Interface       Date:  2019-06-26       Impact factor: 4.118

3.  Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers.

Authors:  Sarwar Beg; Suryakanta Swain; Harendra Pratap Singh; Ch Niranjan Patra; M E Bhanoji Rao
Journal:  AAPS PharmSciTech       Date:  2012-10-16       Impact factor: 3.246

4.  Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data.

Authors:  Tycho Heimbach; Binfeng Xia; Tsu-han Lin; Handan He
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

5.  Disintegration mediated controlled release supersaturating solid dispersion formulation of an insoluble drug: design, development, optimization, and in vitro evaluation.

Authors:  Sanjay Verma; Varma S Rudraraju
Journal:  AAPS PharmSciTech       Date:  2014-09-05       Impact factor: 3.246

6.  In vitro and in vivo Evaluation of Ibuprofen Nanosuspensions for Enhanced Oral Bioavailability.

Authors:  Mohsen Hedaya; Farzana Bandarkar; Aly Nada
Journal:  Med Princ Pract       Date:  2021-04-06       Impact factor: 1.927

7.  Improving the Solubilization and Bioavailability of Arbidol Hydrochloride by the Preparation of Binary and Ternary β-Cyclodextrin Complexes with Poloxamer 188.

Authors:  Md Khalid Anwer; Muzaffar Iqbal; Mohammad Muqtader Ahmed; Mohammed F Aldawsari; Mohd Nazam Ansari; Essam Ezzeldin; Nasr Y Khalil; Raisuddin Ali
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-26

8.  Facile synthesis of PEI-based crystalline templated mesoporous silica with molecular chirality for improved oral delivery of the poorly water-soluble drug.

Authors:  Wei Xin; Yumei Wang; Yan Bian; Jiahui Lin; Wenhao Weng; Xinyi Zhao; Kaijun Gou; Xianmou Guo; Heran Li
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

9.  Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix.

Authors:  Yang Guo; Ting Zhong; Xiao-Chuan Duan; Shuang Zhang; Xin Yao; Yi-Fan Yin; Dan Huang; Wei Ren; Qiang Zhang; Xuan Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Superiority of L-tartaric Acid Modified Chiral Mesoporous Silica Nanoparticle as a Drug Carrier: Structure, Wettability, Degradation, Bio-Adhesion and Biocompatibility.

Authors:  Beibei Hu; Jianxin Wang; Jing Li; Sanming Li; Heran Li
Journal:  Int J Nanomedicine       Date:  2020-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.